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Abstract
This work is a feasibility study of a radiation treatment
unit with laser-driven protons based on a state-of-the-art
energy selection system employing four dipole magnets
in a compact shielded beamline. The secondary radiation
emitted from the beamline and its energy selection system
and the resulting effective dose to the patient are assessed.
Further, it is evaluated whether or not such a compact sys-
tem could be operated in a conventional treatment vault
for clinical linear accelerators under the constraint of not
exceeding the effective dose limit of 1 mSv per year to
the general public outside the treatment room. The Monte
Carlo code Geant4 is employed to simulate the secondary
radiation generatedwhile irradiating a hypothetical tumor.
The secondary radiation inevitably generated inside the
patient is taken into account as well, serving as a lower
limit. The results show that the secondary radiation ema-
nating from the shielded compact therapy system would
posea serious secondarydose contamination to the patient.
This is due to the broad energy spectrum and in particu-
lar the angular distribution of the laser-driven protons,
which make the investigated beamline together with the
employed energy selection systemquite inefﬁcient. The sec-
ondary radiation also cannot be sufﬁciently absorbed in a
conventional linear accelerator treatment vault to enable
a clinical operation. A promising result, however, is the
fact that the secondary radiation generated in the patient
Untersuchung zur Sekundärstrahlung und
zum Strahlenschutz bei der Strahlentherapie
mit Laser-beschleunigten Protonen
Zusammenfassung
Diese Arbeit ist eine Machbarkeitsstudie für ein Strahlen-
therapiesystem mit Laser-beschleunigten Protonen,
das auf dem aktuell diskutierten Energieselektions-
system mit vier Dipolmagneten in einem kompakten,
abgeschirmten Strahlführungssystem basiert. Die von der
Strahlführung und dem Energieselektionssystem emit-
tierte Sekundärstrahlung und die resultierende effektive
Dosis des Patienten werden ausgewertet. Weiterhin wird
untersucht, ob ein solches kompaktes System in einem
konventionellen Bestrahlungsbunker für klinische Linear-
beschleuniger betrieben werden könnte, ohne dass
die effektive Dosis für die Öffentlichkeit außerhalb
des Bestrahlungsraumes 1 mSv pro Jahr überschrei-
tet. Der Monte-Carlo-Code Geant4 wurde verwendet,
um die entstehende Sekundärstrahlung während der
Bestrahlung eines hypothetischen Tumors zu simulieren.
Die unausweichlich im Patienten selbst generierte
Sekundärstrahlung wird ebenfalls berücksichtigt
und dient als untere Grenze. Die Resultate zeigen,
dass die Sekundärstrahlung, die das abgeschirmte
kompakte Bestrahlungssystem verlässt, eine ernst-alone could be very well shielded by a regular treatment
vault, allowing the application of more than 100 fractions
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of 2 Gy per day with protons. It is thus theoretically possi-
ble to treat patients with protons in such treatment vaults.
Nevertheless, the results show that there is a clear need
for alternative more efﬁcient energy selection solutions for
laser-driven protons.
Keywords: Monte Carlo, laser-driven protons,
proton therapy, secondary radiation
Energiespektrum und insbesondere die Winkelverteilung
der Laser-beschleunigten Protonen, die das untersuchte
Strahlführungssystem zusammen mit dem verwendeten
Energieselektionssystem sehr inefﬁzient machen. Die
Sekundärstrahlung kann auch von einem konventionellen
Bestrahlungsbunker für Linearbeschleuniger nicht ausrei-
chend abgeschirmt werden, um einen klinischen Betrieb
zu ermöglichen. Ein vielversprechendes Resultat hinge-
gen ist die Tatsache, dass die nur im Patienten
erzeugte Sekundärstrahlung sehr wohl von einem nor-
malen Bestrahlungsbunker abgeschirmt werden kann. Ein
konventioneller Bestrahlungsraum würde es erlauben,
über 100 Fraktionen zu je 2 Gy pro Tag mit Proto-
nen zu applizieren. Es ist daher theoretisch möglich in
solchen Bestrahlungsräumen Patienten mit Protonen zu
behandeln. Allerdings zeigen die Resultate eindeutig, dass
alternative, efﬁzientere Ansätze zur Energieselektion von
Laser-beschleunigten Protonen notwendig sind.
Schlüsselwörter: Monte Carlo, Laserbeschleunigung,
Protonentherapie, Sekundärstrahlung
1 Introduction
Protons are renowned in radiation therapy for their abil-
ity to place dose in a tumor volume very precisely due to
the characteristic Bragg peak. It is therefore desirable to have
compact devices for proton therapy at hand that are easily
available. So far, proton therapy is only performed in ded-
icated facilities using a cyclotron or synchrotron for proton
acceleration and enormous particle gantries for their applica-
tion to the patient. Protons can be accelerated with lasers as
well, making it theoretically possible to build compact single
room systems since the protons are accelerated over a very
short distance and the laser light can be deflected around the
patient in a gantry requiring much less space than the mag-
nets necessary to deflect a proton beam [1]. In contrast to
conventionally accelerated protons, laser-driven protons typ-
ically exhibit a broad energy spectrum, making it possible to
select the protons with the desired energy, but at the same time
this requires a solution for energy selection and the stopping
of protons with unwanted energy which will inevitably pro-
duce a lot of secondary particles. Also, experimental results
with laser-driven protons have not yet reached energies that
are high enough for clinical applications.
The work presented here is a feasibility study of a hypo-
thetical compact laser-driven proton therapy system (based
on the current knowledge about laser-driven particle acceler-
ation) regarding the dose delivered to the patient by secondary
is based on simulations using the Monte Carlo code Geant4
[2,3]. The central question posed here is whether or not such a
hypothetical compact device could be operated in a standard
linac room as replacement of an existing linac. Such a compact
therapy system operated with laser-driven protons and without
the need of building a new treatment vault might be consid-
erably cheaper than a conventional dedicated proton therapy
facility, therefore possibly making proton therapy available to
much more patients.
The energy selection technique applied here uses four
dipole magnets and is based on the work of Fourkal et al.
[4] (see Fig. 1 for an outline of the corresponding beam-
line). Such systems have been realized experimentally [5,6]
and are frequently referred to in the relevant literature. This
concept may therefore still be considered the current state of
research, although doubts about its applicability for clinical
use are pertinent (e.g. regarding the efficiency of the system,
cf. [7]) and novel concepts are being developed to overcome
this limitation [8]. The assumed initial energy spectrum of the
protons used here is very broad (with energies up to 300 MeV)
and derived by extrapolating current experimental spectra to
higher energies (as done in [9] and [8]). This is based on the
target normal sheath acceleration (TNSA) mechanism [10]
or other acceleration regimes that show broad energy spectra
(e.g. [11]). Energies of 300 MeV have not yet been experimen-
tally shown (the current record is about 160 MeV [12]), but are
a prerequisite for clinical applications (required energy rangeparticles and with regard to radiation protection considerations
if such a system is operated in a conventional (existing) treat-
ment room designed for clinical electron linear accelerators
(linacs) for therapeutic electron and photon beams. This studyfor proton therapy: 70 MeV to 250 MeV). In our study, we
will investigate in more detail whether the proposed energy
selection system (with some modifications to make it more
realistic) is feasible for clinical applications, with a focus on
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Figure 1. Layout of the proton beamline, shielding components and
dose detectors A – G. The broken lines indicate the optional water
phantom and the detector sphere that records the emitted secondary
radiation. Materials are coded by color: lead (grey), polyethylene
(yellow), tungsten (brown), iron (green) and water (blue). Drawing
is to scale.
radiation protection. A shielding design for such a beamline
was proposed by Fan et al. [9] and was adapted here to study
the secondary radiation that is found outside the beamline,
being relevant for the patient, and outside of the treatment
room, being relevant for radiation protection of the personnel.
2 Materials and Methods
2.1 Reproducing the set-up of Fan et al.
Based on Monte Carlo simulations using Fluka, Fan et al.
[9] proposed a shielding design for a beamline containing an
energy selection system for the polyenergetic protons gen-
erated by a high-intensity laser pulse acting on a thin foil
[9]. This design is the basis for our studies. Our evaluation
of the produced secondary radiation in the beamline and the
patient is carried out using the Monte Carlo simulation toolkit
Geant4 version 9.2 (patch 2) [2,3], because it is more flexible
and powerful when it comes to complex or dynamic problems.
In a first step we transferred the geometry used by Fan et al.
to Geant4 in order to reproduce their results and to compare
Geant4 to Fluka. For the physics processes we used the pre-
defined physics list QGSP BIC HP, which is recommended
for medical physics applications and which uses the high-
precision data-driven neutron package. The dose evaluation
in the dose detectors allowed differentiating between the con-
tributions from neutrons and photons. This is realized by using
the G4VUserTrackInformation class to mark the cascade ofd. Phys. 25 (2015) 112–122
secondary particles as originating from a neutron or a photon,
respectively. The energy deposited in the volumes of interest,
which are seven water-filled detector spheres with 4 cm diam-
eter (positioned as by Fan et al.), is accumulated during the
simulation, divided by the mass of the water sphere and then
weighted by a quality factor Q to obtain the dose equivalent
H (to be comparable to the results published by Fan et al.).
We use a quality factor of 1 for photons and 20 for neutrons.
The neutron quality factor was chosen to be a conservative
estimation and it was motivated by the weighting factor for the
equivalent dose HT from ICRP Publication 60 [13]. The value
given there is a little bit higher than the one from ICRP Pub-
lication 103 [14]. Fan et al. used quality factors from NCRP
Report 38 [15]. Our results more or less confirm the results of
Fan et al. The dose values from our simulation are in the same
order of magnitude, mostly in the range of being one to four
times larger than the ones of Fan et al. The only remarkable
deviation from their results is that we found a significant con-
tribution to the dose coming from photoneutrons, being in the
same order as the dose from x-rays. The differences between
the results of Fan et al. and ours can be attributed to slight
deviations of the geometrical set-up (not all distances were
numerically given by Fan et al.) and the different quality fac-
tors. Taking the mean energy of the secondary neutrons and
applying the respective quality factor from NCRP Report 38
we arrive at nearly exactly the same neutron dose as Fan et al.
The remaining differences in the total dose (including pho-
tons) must be due to a different implementation of the physics
processes in Fluka and Geant4. This holds especially for the
photoneutron production. Generally, Geant4 seems to tend to
generate more secondary particles than Fluka. Nevertheless,
this first step confirms the usability of Geant4 and our dose
scoring method for further studies in a modified geometry.
2.2 Modiﬁed set-up of the proton beamline
On the basis of the beamline proposed by Fan et al. we
developed in a second step a similar beamline with modified
properties (Fig. 1) to make the set-up more realistic for possi-
ble clinical applications. This includes the source parameters
(in particular the angular distribution of the primary particles),
the operating range of the energy selection system (to allow
energies below 93 MeV), the arrangement of strength of the
magnets and the shielding. The magnetic field strength was
decreased from 4.4 T to 3.5 T in the simulation to reduce
the technical difficulties realizing this field strength. This had
an impact on the geometry of the energy selection system as
well to make sure that protons with kinetic energies in the
therapeutic range can still pass. Therefore, the height of the
magnets was extended from 20 cm to 24 cm and the drift space
between the magnets increased from 5 cm to 10 cm. To ease
the problem of ensuring homogeneous magnetic fields, the last
three magnets were cut in size. 10 cm of their lower part were
removed. The lower part of the first magnet on the other hand
is essential to deflect the electrons that are also produced by
. Phys. 25 (2015) 112–122 115
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Figure 2. Dose distribution in the hypothetical tumor that is situated
at a depth from 14 cm to 22 cm in a 30 cm water phantom. Protons of
15 different Gaussian energy distributions with a standard deviationS. Faby, J.J. Wilkens / Z. Med
the laser pulse in the target foil. The energy selection system
is now able to allow protons with kinetic energies between 65
MeV and far above 250 MeV to pass; before, the lower limit
was 93 MeV. The thickness of the tungsten aperture between
the second and third magnet was increased from 5.3 cm to
10 cm to allow a better collimation and thus a more restric-
tive energy selection that generates a proton beam with only a
small spread in energy. The movable part of the selector does
not extend over the whole width of 20 cm, but it is only 4 cm
wide, the left and right side part are made of a solid block for
better shielding. This generates a rectangular shaped aperture;
a circular aperture would have been more appropriate, but for
shielding considerations it is not of significance. Further, we
introduced a 2.2 cm thick iron vacuum chamber that covers the
whole inside of the beamline. The vacuum pressure was fixed
to 1 × 10−6 mbar. Outside the beamline is air. The source was
positioned at 2 cm distance from the primary collimator, which
has an opening angle of 0.02 rad. A two-dimensional Gauss-
ian angular distribution with standard deviation of 0.02 rad
was assumed for the protons and electrons emerging from the
source. All other parameters for the source, the beamline and
the used materials were taken from Fan et al. [9].
2.3 Irradiation conditions
To simulate a realistic tumor irradiation, a water phantom
consisting of a cubic box with 30 cm side length was pos-
itioned at 10 cm distance from the beamline exit (Fig. 1).
Inside the water phantom a tumor of 8 cm length and a 4 × 4
cm2 cross section positioned at a depth between 14 cm and
22 cm was assumed. The kinetic energy of protons needed
to cover the tumor ranges from 141 MeV to 182 MeV. The
beamline had to be characterized to find appropriate sett-
ings for the aperture to generate a proton beam that is as
monoenergetic as possible and to be able to quantify and then
compensate for losses occurring in the beamline during the
energy selection process. Opening the aperture ±0.4 MeV
around the center position of the desired energy on the aper-
ture gave useful results. The aperture positions were always
calculated for a proton trajectory starting on the central axis
of the beamline without exhibiting any exit angle from the
source. The result is a proton beam with a Gaussian energy
distribution, which is due to the Gaussian angular distribution
of the protons, with a standard deviation of 2.34 MeV. This
standard deviation is independent of the chosen mean energy
of the proton beam because we defined the aperture opening
in energy and not in space. This ensures a constant quality of
the proton beam. Obtaining a proton beam with a relatively
small energy spread has its price; only about 1% of the initial
protons from the source having the desired energy pass the
aperture. This figure is energy-dependent, although we chose
the angular distribution of the protons to be constant for all
energies, because the deflection of the protons in the magnetic
dipoles of the energy selection system is energy-dependent.
The energy dependence exhibits a weaker deflection ofof 2.34 MeV as generated by the energy selection system contributed
with different weights.
protons with higher kinetic energies and thus at higher ener-
gies adjacent energies are situated spatially closer together
on the aperture which necessitates the aperture to restrict the
accepted proton angles further. This leads to a decreasing effi-
ciency of the energy selection system with higher energies.
We developed a model to predict these proton losses in the
aperture by assuming that the aperture cuts a rectangle out of
the circular proton distribution, which is defined by the open-
ing angle of the primary collimator. After the behavior of the
beamline with respect to the exit proton beam was defined and
the standard deviation of the Gaussian energy spectrum was
known, treatment planning for the hypothetical tumor in the
water phantom was carried out in a very basic manner. The
tumor was divided into 15 equidistant slices in depth. In each
slice a Bragg peak was placed. For the analytical description of
the Bragg peak an approximate formula was used that allows
incorporating the standard deviation of a non-monoenergetic
Gaussian-shaped proton beam [16]. The weights for the 15
different energies to ensure a homogeneous coverage of the
tumor (with a single fraction of 2 Gy) were determined by for-
mulating a non-negative least-squares optimization problem.
The weights were converted to proton numbers, corrected for
the energy specific losses and then the total number of protons
that needs to be emitted by the source was determined. The
resulting dose distribution of 2 Gy over the length of the tumor
is shown in Figure 2, for a total number of 2.4 × 1010 protons
to enter the patient. It is not a perfect spread-out Bragg peak,
but fully sufficient for this study of the produced secondary
radiation. After all losses had been taken into account, how-
ever, the total number of protons that need to be emitted by
the source amounts to 1.6 × 1016. This reveals the very bad
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efficiency of about 10−6 of the beamline in producing a proton
beam with a narrow energy width. The biggest part is due to the
broad, thermal energy spectrum, contributing around 10−4 to
the efficiency because only 1/10000 of all protons emitted by
the source have an appropriate kinetic energy. The remaining
factor of 10−2 originates from the angular distribution of the
protons, making it necessary to block a lot of protons in the
primary collimator and the aperture that effectively acts as a
second collimator. In the simulation program, the total num-
ber of 1.6 × 1016 protons is given to the source to be emitted.
The aperture automatically adjusts its position and opening
width to change the energy of the proton beam each time the
different threshold proton numbers defined by the weights for
the 15 energies are surpassed. In this way it is ensured that the
right number of protons with the required energy modulation
reaches the water phantom. The number of electrons generated
along with the protons in the target foil is calculated analo-
gously to [9], using the same median energies for the electrons
and protons as given there, resulting in 1.0 × 1017 electrons
generated along with the 1.6 × 1016 protons. To save compu-
tation time, the real simulation was carried out with 1 × 1011
protons and electrons, and the results were scaled accord-
ingly afterwards. Fan et al. determined 9.7 × 1013 protons and
6.06 × 1014 electrons to be necessary for a 1 Gy dose frac-
tion in the hypothetical tumor described above. For the same
dose, our particle numbers are nearly two orders of magnitude
higher. To calculate the proton number, Fan et al. assumed that
one can directly use all the protons having passed the primary
collimator to cut the desired proton spectrum out of it, meaning
that the energy selection process can be done without losses
and for multiple energies at the same time. Here, on the other
hand, a modulated proton spectrum was build based on 15 dif-
ferent quasi-monoenergetic proton beams and by considering
a more realistic energy selection by the aperture, taking the
angular distribution of the protons into account.
2.4 Scoring geometry
Two trials were carried out with the set-up in Figure 1.
The first trial is concerned with the dose outside the beamline
shielding, especially with the additional dose for the patient.
The dose was evaluated in the small water spheres tagged
with capital letters A – G. Of those detectors A, B and G are
of interest for the additional patient dose. As already discussed
above, only a very small fraction of all protons actually leaves
the beamline. To do a conservative estimation the aperture is
thus completely closed here. For this study we used the proton
and electron numbers derived above.
In the second trial the small water spheres were replaced
by the water phantom and a detector sphere to record the total
secondary radiation generated during a patient irradiation. The
hypothetical tumor in the water phantom was irradiated with
2 Gy using the techniques described above. We simulated also
the secondary radiation originating from the water phantomd. Phys. 25 (2015) 112–122
only, excluding the one from the beamline. This radiation will
serve to obtain the lower limit for the dose outside the shielded
treatment room, because it is the secondary radiation gen-
erated in the patient that cannot be avoided. This case was
simulated by directly emitting the perfectly modulated proton
spectrum from the source, so no further energy selection was
necessary and all shielding components were removed. It is
equal to the case of a perfectly shielded beamline or an energy
selection system and/or source that is able to somehow make
all protons usable.
The secondary radiation emanating from the beamline and
water phantom is registered by defining a spherical shell
(radius 1.23 m) around the set-up, as illustrated by the bro-
ken line circle in Figure 1. Every photon and neutron that
passes through this sphere is registered and binned in the
following way: The sphere is represented in spherical coor-
dinates, i.e. the polar angle p and the azimuthal angle p
to identify the particle’s position on the sphere. The particle’s
direction is given by a vector, defining again angles d and d.
All angles are binned in 10◦ steps. In addition, the particle’s
kinetic energy is registered in 10 MeV steps.
2.5 Simulation of the treatment room
A realistic treatment room was implemented in Geant4 to
study the radiation protection of the personnel according to
the floor plan of a clinical linear accelerators designed for
15 MV photons (Fig. 3). The walls are made of three differ-
ent materials: normal concrete (Portland concrete, density of
2.3 g cm−3), heavy barite concrete (density of 3.35 g cm−3)
and borated paraffin (80% paraffin wax and 20% boric acid),
which is used for the radiation protection door. For the com-
position and density of these materials we applied widely used
values that were taken from PNNL report 15870 [17]. Inside
and outside the room is air. The floor has a thickness of 1.0 m
and is made of normal concrete. The ceiling is divided into
three parts from left to right. The first part extends from the left
wall to the beginning of the primary beam stopper, which is the
thick dark grey part. The first part of the ceiling has a thickness
of 1.4 m and is made of normal concrete. The second part only
extends over the width of the primary beam stopper, having
a thickness of 1.5 m and being made of barite concrete. The
third part is then on the right side of the primary beam stopper
with a thickness of 1.0 m and normal concrete as material.
Inside, the room has a height of 3.0 m everywhere. The pri-
mary beam stopper situated next to detector G has a thickness
of 1.49 m, whereas the one next to detector E is 1.58 m thick.
The dashed boxes represent the dose detectors A – M; they are
2 × 2 × 0.5 m3 boxes filled with water. The dose values from
these detectors have to be compared to the limit of an effective
dose E of less than 1 mSv in a calendar year to the general
public. Since here the effective dose E and not the equivalent
dose HT needs to be determined, we assumed a homogeneous
whole body irradiation because in that case HT is equivalent to
E. This assumption is valid under the condition of small dose
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Table 1
Dose equivalent per 2 Gy absorbed treatment dose in the tumor in detectors A – G (Fig. 1) for 1.63 × 1016 protons and 1.02 × 1017 electrons.
The last column gives the total absorbed dose in Gy per 2 Gy absorbed treatment dose.
Detector Proton source Electron source Total (Sv) Total (Gy)
Neutrons (Sv) Gammas (Sv) Photoneutrons (Sv) X-rays (Sv)
A 7.14 × 10−1 1.25 × 10−3 1.72 × 10−2 1.72 × 10−1 9.04 × 10−1 2.10 × 10−1
B 2.08 × 10−1 6.94 × 10−4 6.58 × 10−4 2.37 × 10−4 2.10 × 10−1 1.14 × 10−2
C 4.15 × 10−1 6.49 × 10−3 3.08 × 10−2 1.83 × 10−2 4.71 × 10−1 4.71 × 10−2
D 2.50 × 10−1 8.62 × 10−3 5.49 × 10−2 5.10 × 10−2 3.65 × 10−1 7.49 × 10−2
E 2.40 × 10−1 8.55 × 10−3 5.25 × 10−2 −2 −1 −2
F 3.36 × 10−1 4.82 × 10−3 4.61 × 10−2
G 1.43 × 10−1 2.10 × 10−4 2.05 × 10−3
2 m A
B
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DE
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L M
1.58 m
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laser
Figure 3. Floor plan of the linac treatment room and the positions of
the detectors A – M. The position of the detector sphere, including
the beamline, the water phantom and a hypothetical robotic gantry
arm with a laser is only shown for clarification purposes. The boxes at
the primary beam stoppers indicate the optional additional shielding.
The broken lines give the positions of the water filled detectors. The
arrows indicate a detector position beneath the floor or above the
ceiling. Materials are coded by color: barite concrete (dark grey),
normal concrete (grey), borated paraffin (red), polyethylene (yellow)
and iron (green). Drawing is to scale.
gradients at the detector positions, which is reasonable behind
the thick concrete shielding. The dose scoring method is the
same as before, we assumed a conservative quality factor of
20 for the dose coming from neutrons. To simulate a compact
radiotherapy unit, we assume that the beamline described ear-
lier is mounted on a robotic arm or gantry, which is much
smaller than conventional proton gantries since it does not
require heavy bending magnets (instead, the laser would be
deflected by mirrors, cf. [1]). Beam delivery may be accom-
plished e.g. by rotation and movements of the robotic arm.
Since we assume irradiation techniques with multiple fields
from different directions, the sphere acting as source of the
secondary radiation was turned to point to one third to the6.92 × 10 3.70 × 10 9.24 × 10
1.73 × 10−1 5.60 × 10−1 1.97 × 10−1
9.61 × 10−2 2.41 × 10−1 1.04 × 10−1
floor, one third to the left and one third to the right primary
beam stopper during the simulation using a total of 7.5 × 108
neutrons and photons each.
3 Results
3.1 Dose to the patient
The results of the first trial with emphasis on the additional
dose to the patient are shown in Table 1 with the contrib-
utions from the different sources of secondary radiation. The
dose values are given in Sv per 2 Gy treatment fraction. For
the patient, detectors A and B are of highest relevance. Gen-
erally, the resulting total dose is quite high. For detector A it
approaches 1 Sv/(2 Gy). The other detectors show dose values
that are a factor 2 to 3 lower. This is due to the missing outer
beamline shielding in front of detector A since it is positioned
right at the beam exit. The uncertainties of these results were
estimated by calculating the standard deviation of the results
of 125 individual simulation threads, each having 1/125 of
the total particle number to be simulated. This uncertainty
amounts to around 20%, but it can be somewhat higher in
detectors that received much less dose than the others. For an
estimation of the magnitude of the relevant dose values, this
uncertainty is considered to be sufficient.
As expected, the secondary neutrons stemming from pri-
mary protons contribute most to the total accumulated dose.
The second biggest contribution is the x-ray dose from pri-
mary electrons. This makes sense because these two types of
secondary radiation are generated in a direct process from the
primary particles, leading to a high energy and a rather forward
directed angular distribution. Indirectly generated secondary
radiation, i.e. photoneutrons from x-rays generated by elec-
trons or gamma-rays from nuclei excited by protons, exhibits a
spectrum of much lower energies and a quasi-isotropic angular
distribution. The dose contribution of this kind of secondary
radiation is lower by about two orders of magnitude (Tab. 1).
Concerning the spatial distribution of the dose, one can see
high values in the forward direction and in the upward (detec-
tor C) and downward (detector F) direction. This is caused
by the first magnetic field that deflects protons upward and
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Figure 4. Energy fluence of neutrons generated in the beamline and the water phantom by primary protons from the source. The left image
shows the distribution of the positions of the neutrons on the sphere detector, the right image shows the distribution of the directions with
amwhich the sphere detector is passed. The cross marks the primary be
electrons downward. The detectors D and E in the back show
an interesting behavior: In the columns of the directly gen-
erated secondary radiation (neutrons, x-rays) they have the
lowest values, whereas they have the highest in the columns of
the indirectly generated ones (gammas, photoneutrons). This
supports the above statements about the angular distributions.
The last column of Table 1 shows the total absorbed dose
without any weighting factor to be able to compare it to
the 2 Gy treatment dose. Detector A reveals that the patient
receives an additional dose of one tenth of the planned dose in
the tumor region. For detector G, being further away from the
beamline exit, it is one twentieth. This is still significant and
disturbs the carefully planned dose distribution. In detector B,
which is positioned a bit off axis and therefore shielded better,
the additional dose is two orders of magnitude lower than the
prescribed dose.
3.2 Dose outside of the treatment room
The secondary radiation that was recorded in the second
trial with the sphere during the irradiation of the water phan-
tom is visualized exemplarily in Figures 4 and 5. Each figure
contains two two-dimensional arrays: the left array shows the
distribution of the energy fluence over the surface of the sphere
(forward direction of the beam is indicated by the black cross),
and the right array shows the distribution of the directions with
which the particles left the sphere. The discrepancies between
these two arrays visualize that the secondary radiation is nei-
ther generated at the center of the sphere, nor does it leave the
sphere in a radial direction (Fig. 1). Figure 4 shows the data
from the secondary neutrons generated by primary protons,direction.
while Figure 5 shows the same for the x-rays stemming from
primary electrons. The figures support the above statements
about the characteristics of the secondary particles. The neu-
trons leave the sphere mainly with an angle of around 45◦
to the central beam axis. There is a small emphasis on the
upward direction due to the upward deflection of the protons
in the first magnetic field. The direction straight forward is
shielded by the beamline itself and the water phantom. The
hot spot at the rear of the sphere is caused by neutrons gen-
erated in the primary collimator, which absorbs about 88%
of all primary protons and electrons. In both arrays diago-
nal, horizontal and vertical stripes with lower energy fluence
disturb the continuous distribution of the secondary particles.
This is caused by the rectangular beamline shielding box. The
particles that travel on a two- or three-dimensional diagonal
through the shielding experience an effective shielding that
is by a factor
√
2 or
√
3 higher than the shielding effect in
a direction orthogonal to the shielding surface. These effects
become more obvious in Figure 5 in the array showing the
distribution of the particle positions on the sphere. Four spots
are generated around the central rear hot spot. Concerning
the directions, most x-rays are downward directed around 90◦
because they are generated by electrons deflected downward
in the first magnetic field. Some of the x-rays that are gener-
ated in the lower shielding wall are reflected upward and cause
the less intense spot around 90◦ upward. These arrays can also
be used to improve the shielding: especially the back and the
lower part of the beamline shielding are weak spots and may
be reinforced. In total, the sphere registered 9.8 × 1013 sec-
ondary neutrons and 7.3 × 1013 secondary photons generated
by primary protons and for the primary electrons the resulting
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Figure 5. Energy fluence of photons (x-rays) generated in the beamline by primary electrons from the source. The left image shows the
e r
on.
distribution of the positions of the x-rays on the sphere detector, th
sphere detector is passed. The cross marks the primary beam directi
secondary particles were 2.1 × 1013 neutrons and 5.4 × 1014
photons.
The results of the secondary radiation that was detected
outside the shielded linac treatment room in detectors A – M
(Fig. 3) is presented in Table 2. Here still a radiation weight-
ing factor of 20 was used for the neutrons. Whereas this was
a conservative assumption in the previous context, this is the
correct weighting factor to be applied here. The neutrons out-
side the concrete shielding have been attenuated and have
now a mean energy of a little bit less than 1 MeV. According
to ICRP Publication 103, a neutron with a kinetic energy of
approximately 0.9 MeV has a weighting factor of 20.6 and
therefore the effective dose values shown in Table 2 are not
Table 2
Effective dose values outside the treatment room in detectors A – M (F
with 2 Gy from three directions with the beam line.
Detector Primary protons
Neutrons (Sv) Gammas (Sv)
A 1.85 × 10−5 4.73 × 10−8
B 2.96 × 10−5 4.57 × 10−7
C 3.66 × 10−5 7.13 × 10−7
D 3.39 × 10−5 7.10 × 10−8
E 2.09 × 10−5 2.99 × 10−10
F 3.61 × 10−5 2.72 × 10−7
G 2.81 × 10−5 4.65 × 10−10
H 9.65 × 10−6 1.26 × 10−8
I 3.57 × 10−6 7.92 × 10−9
J 2.44 × 10−5 3.68 × 10−8
K 7.88 × 10−6 2.36 × 10−8
L 4.66 × 10−4 3.06 × 10−6
M 2.12 × 10−5 7.76 × 10−10ight image shows the distribution of the directions with which the
conservative anymore. Outside the beamline the mean energy
of the neutrons was 13.9 MeV. The order of importance in
which the four contributions add to the total effective dose is
the same as for the dose outside of the beamline (Table 1). The
neutrons originating from primary protons still dominate the
dose by at least one order of magnitude. Detector L exhibits
a much higher effective dose than all other detectors. This is
due to the fact that the proton beam pointed directly towards
this detector for one third of the irradiation time and the floor
is only made of 1 m normal concrete. Beneath the floor is
nothing but ground, so this value does not need to be con-
sidered. Apart from detector L, the highest dose was found
in detector F, being 4.48 × 10−5 Sv/(2 Gy). So the number
ig. 3) for the irradiation of a hypothetical tumor in a water phantom
Primary electrons Total (Sv)
Photoneutrons (Sv) X-rays (Sv)
5.00 × 10−7 2.35 × 10−7 1.93 × 10−5
3.25 × 10−7 2.89 × 10−6 3.33 × 10−5
4.13 × 10−7 4.50 × 10−6 4.22 × 10−5
1.16 × 10−7 3.01 × 10−7 3.44 × 10−5
1.26 × 10−8 1.93 × 10−9 2.09 × 10−5
1.08 × 10−7 8.27 × 10−6 4.48 × 10−5
2.74 × 10−8 1.92 × 10−9 2.81 × 10−5
3.39 × 10−8 5.89 × 10−8 9.76 × 10−6
3.07 × 10−8 3.06 × 10−8 3.64 × 10−6
1.54 × 10−7 1.65 × 10−7 2.47 × 10−5
1.36 × 10−7 1.10 × 10−7 8.15 × 10−6
2.37 × 10−6 1.81 × 10−5 4.90 × 10−4
6.25 × 10−8 5.07 × 10−9 2.13 × 10−5
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Table 3
Effective dose values per 2 Gy treatment dose outside the treatment
room in detectors A – M (Fig. 3) generated by secondary radia-
tion exclusively from the water phantom and not from the beam
line during the irradiation of a hypothetical tumor with 2 Gy using a
modulated proton spectrum to generate the dose distribution shown
in Figure 2.
Detector Primary protons Total (Sv)
Neutrons (Sv) Gammas (Sv)
A 9.40 × 10−10 4.67 × 10−12 9.45 × 10−10
B 5.58 × 10−10 2.81 × 10−11 5.86 × 10−10
C 9.79 × 10−10 4.40 × 10−11 1.02 × 10−9
D 1.76 × 10−9 7.72 × 10−12 1.77 × 10−9
E 1.51 × 10−8 2.77 × 10−14 1.51 × 10−8
F 4.59 × 10−10 1.99 × 10−11 4.79 × 10−10
G 2.07 × 10−8 4.56 × 10−14 2.07 × 10−8
H 4.59 × 10−10 7.72 × 10−13 4.59 × 10−10
I 1.04 × 10−10 1.35 × 10−12 1.05 × 10−10
J 1.02 × 10−9 2.29 × 10−12 1.02 × 10−9
K 2.34 × 10−10 4.18 × 10−12 2.38 × 10−10120 S. Faby, J.J. Wilkens / Z.
of treatments with a 2 Gy fraction that is possible before the
limit of an effective dose of 1 mSv per year is exceeded eval-
uates to 22.3. This value is by far not enough for a clinical
application. The numerous high-energy neutrons cannot be
adequately shielded by a standard linac vault.
Since the intrinsic shielding of the linac treatment room was
proved to be not sufficient, we considered applying additional
shielding. Also heavier shielding of the beamline itself would
be theoretically possible, but due to weight limitations for a
movable beamline on a compact robotic arm it was not con-
sidered further. The beamline’s weight is already at the limit
of what a robotic arm can move. To evaluate the effect of addi-
tional shielding applied in reasonable quantities, the previous
simulation was carried out again. Iron and polyethylene (PE)
were used to reinforce the primary beam blocker next to detec-
tors E and G, as indicated in Figure 3 by the hatched areas. At
detector E iron with 5 cm thickness was applied on the inside
and 15 cm PE on the outside of the barite concrete. In this way
we create a multilayer shielding [9]. The PE is very effective
in shielding low-energy neutrons. The thickness of the addi-
tional shielding was doubled at detector G. 10 cm iron and
30 cm PE were considered the maximum realistic thickness of
additional shielding material possible under practical aspects.
The thinner additional shielding showed a dose decrease to
52% of the dose value without additional shielding measured
at detector E. For detector G we even found a decrease to 31%.
Although this is a significant dose reduction that allows three
times more treatments, it is still far from being enough.
3.3 Secondary radiation from the water phantom only
In the last simulation the secondary radiation from the water
phantom only was simulated that represents the radiation gen-
erated in the patient during the irradiation. This radiation
serves as estimation for the lower limit because it cannot be
avoided. If the treatment room shielding fails to protect the
outside from this radiation, then it is obvious that patients
cannot be treated with protons in such rooms under any cir-
cumstances. The additional shielding was removed here from
the primary beam stoppers. The results are shown in Table 3.
This time no electrons from the target foil had to be considered,
therefore there is only secondary radiation from protons. The
effective dose is now much lower than before, by three to four
orders of magnitude. If detector L is ignored again, the highest
dose is found in detector G with 2.07 × 10−8 Sv/(2 Gy). Com-
pared to the limit of 1 mSv per year, this results in more than
48300 possible treatments with 2 Gy per year. This is equal
to more than 130 treatments every day over 365 days, being
very well sufficient for a clinical application. If we assume
that a 2 Gy fraction is delivered within one minute, the mean
dose rate during this minute at detector G is 1.2Sv/h, which
is well below any occupational limits. These results are very
promising since they show that it is possible to treat patients
with protons in a standard linac room, at least from the radia-
tion protection point of view. The properties of the laser-drivenL 2.75 × 10−7 3.55 × 10−10 2.76 × 10−7
M 2.88 × 10−10 4.87 × 10−14 2.88 × 10−10
protons with broad spectra considered here are not suited for
a compact beam line; the energy selection system with an
efficiency of 10−6 is too inefficient. The efficiency could be
improved by accepting a broader energy width of the proton
beam emerging from the beamline and to allow broad energy
spectra at least in the middle of the target volume [7].
4 Discussion
In a first step (data not shown) we found a comparable
dose at different positions outside the beamline with Geant4
as Fan et al. with Fluka. Then we modified the set-up in
order to make it more realistic for clinical applications and
we included a more detailed simulation of the energy selec-
tion process (including the angular proton distribution and
their energy spread, see section 2.3), which led to a much
higher number of necessary primary protons and this in turn
caused a rise of the secondary dose values of around two orders
of magnitude. This resulted in an additional dose of several
hundreds of mSv to different organs in the patient, increasing
the risk of developing secondary cancers. For conventional
proton therapy using the passive scattering technique values
of up to 2 × 10−3 Sv/Gy are given in the literature for internal
(radiation generated in the patient) and external (secondary
radiation from the device) sources [18–20], but generally they
are at least one order of magnitude lower. The values given
in Table 1 are external secondary radiation in this sense. Our
results are therefore at least two orders of magnitude higher
than in a passive scattering system.
In a second part we studied the performance of a standard
treatment room designed for linacs with respect to its shielding
properties when exposed to the secondary radiation generated
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in a compact laser-driven proton therapy system and the irra-
diated patient. Supposing a limit of 1 mSv effective dose in
a calendar year outside the treatment room, we found that
the number of possible treatment fractions is much too low
for any clinical applications. Additional shielding in realistic
amounts did not change this number sufficiently.
Both results (dose to patient and dose outside treatment
room) highlight the inefficiency of the proposed energy
selection system based on four dipole magnets and our mod-
ifications described above, and there is a clear need for
alternative solutions to make laser-driven proton acceleration
a feasible clinical tool. The high inefficiency of the beam-
line that was simulated here is mainly due to the proton
source properties, namely the energy and angular distribution
of the protons. The fast electrons generated along with the
protons are of importance for shielding considerations, too.
These source properties depend on the proton acceleration
mechanism considered, e.g. the target normal sheath acceler-
ation (TNSA) mechanism. Going to higher laser intensities
and different acceleration mechanisms like the radiation pres-
sure acceleration might render the proton source properties
much more favorable for an application in a compact beam-
line, because of its narrower energy and angular spread [21].
In particular, it would be a considerable advantage if (tunable)
quasi-monoenergetic spectra could be produced by the laser
[22,23]. In addition, a better capturing and focusing of the pro-
tons (e.g. by using a pulsed solenoid [24,25]) could improve
the efficiency by up to two orders of magnitude. First design
studies using pulsed magnets [8,26] are very promising.
To assess whether it is generally possible at all to treat
a patient with protons in a standard linac treatment room,
we only considered the secondary radiation generated in and
emanating from the patient during the irradiation. This serves
as lower limit for the secondary radiation since it cannot be
avoided and it assumes an ideal beamline with no losses and
imperfect shielding. In this case we found that over 130 appli-
cations of 2 Gy per day over 365 days are possible before the
limit of 1 mSv per year is exceeded. This would render a clini-
cal application possible, given that the beamline is sufficiently
efficient, and is therefore a very promising result.
DeMarco et al. carried out a comparable simulation study
with the MCNPX code on the secondary radiation generated
within the patient and the resulting shielding requirements,
using a soft tissue cylinder with 40 cm diameter and 80 cm
length [27]. Apart from the fact that they report the same
behavior of the secondary particles, i.e. neutrons being of high
energy and forward-directed and photons having lower energy
with only a small dependency on direction, their findings
regarding shielding are consistent with what we found. For
the same limit of 1 mSv per year and a comparable concrete
shielding thickness DeMarco et al. found a possible workload
of 20000 Gy per year with 1.6 m concrete shielding in the
forward direction, whereas we found a workload of 96600 Gy
per year with a shielding of 1.5 m barite concrete protecting
detector G. These two results differ by a factor of nearly 5, buthys. 25 (2015) 112–122 121
this can be explained by the fact that the tumor volume irradi-
ated by DeMarco et al. was a factor of 4 bigger, and that in our
study the gantry was only pointing directly towards detector
G for 1/3 of the total irradiation time, meaning that detector
G received on average less intense radiation.
5 Conclusion
In conclusion, the laser acceleration technique that is avail-
able so far is not yet suitable for an application in a compact
beamline that could replace an existing linac, both in terms of
secondary dose to the patient and dose outside of the treatment
room. It is, however, generally possible to treat patients with
protons in a standard linac treatment room that is shielded for
15 MV photons if we consider only the secondary radiation
generated in the patient, i.e. assuming a perfect beamline with
no radiation leakage. This finding is independent from the type
of proton source. Conventional acceleration mechanisms or
the dielectric wall acceleration mechanism [28] could also be
applied. Future improvements of the properties of laser-driven
protons that might occur e.g. at higher laser intensities, may
render it very well possible to apply such proton sources in
compact beamlines. These beamlines might even be a single
room solution and could then replace existing linacs making
thus proton therapy available for a greater public, which is an
appealing thought and motivation for further research.
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